Sanjay Patel completed his medical training in 1993 in Leeds UK, and fully qualified as a general practitioner in 1997, with membership of the royal college of general practitioners. He then worked for a clinical research charity focused on nutrition, metabolism and reproductive medicine.
He has subsequently worked in pharmaceutical clinical research since 2000 and is a Fellow of the faculty of pharmaceutical medicine. He currently works in clinical development as a Senior Director for Prometic Pharma SMT Ltd. having previous roles with Roche, Eli Lilly GSK, Daiichi Sankyo and Boehringer Ingelheim.
He has extensive clinical research experience in diabetes, cardiovascular outcomes, endocrinology, diabetes complications, metabolic diseases and nephrology. His current role focuses on small molecules targeting fibrosis related diseases, including orphan conditions such as Alström Syndrome and Cystic Fibrosis. He is a practicing physician, with weekly clinics at a local London surgery.